347 related articles for article (PubMed ID: 26460798)
1. Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
Muto S; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Int J Oncol; 2015 Dec; 47(6):2082-90. PubMed ID: 26460798
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
3. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
[TBL] [Abstract][Full Text] [Related]
6. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
7. Upregulated TIGIT
Lin F; Hu X; Zhang Y; Ye S; Gu Y; Yan B; Wang L; Jiang Y
Mol Immunol; 2022 Jul; 147():40-49. PubMed ID: 35504057
[TBL] [Abstract][Full Text] [Related]
8. Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs.
Elkord E; Sharma S; Burt DJ; Hawkins RE
Clin Immunol; 2011 Sep; 140(3):218-22. PubMed ID: 21570917
[TBL] [Abstract][Full Text] [Related]
9. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK
J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504
[TBL] [Abstract][Full Text] [Related]
10. Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV.
Degaffe G; Zakhour R; Zhang W; Contreras GA; Bell CS; Rodriguez G; Del Bianco G; Pérez N; Benjamins LJ; Murphy JR; Heresi GP; Tran DQ
Clin Exp Immunol; 2015 Apr; 180(1):108-17. PubMed ID: 25425428
[TBL] [Abstract][Full Text] [Related]
11. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of Helios(+) and Helios(-) T regulatory cell subsets in the circulation of healthy pregnant women.
Kopřivová H; Hájková M; Koucký M; Malíčková K; Holáň V; Krulová M
Scand J Immunol; 2019 Apr; 89(4):e12754. PubMed ID: 30729559
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Iwata T; Uramoto H; So T; Tanaka F
Lung Cancer; 2013 Sep; 81(3):475-479. PubMed ID: 23891508
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T-cells and micrometastasis in lymph nodes of stage I NSCLC.
Hanagiri T; Fukumoto M; Koyanagi Y; Furutani Y; Tanaka F
Anticancer Res; 2014 Dec; 34(12):7185-90. PubMed ID: 25503147
[TBL] [Abstract][Full Text] [Related]
15. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion.
Kim YC; Bhairavabhotla R; Yoon J; Golding A; Thornton AM; Tran DQ; Shevach EM
Blood; 2012 Mar; 119(12):2810-8. PubMed ID: 22294730
[TBL] [Abstract][Full Text] [Related]
16. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
17. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
18. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
19. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
[TBL] [Abstract][Full Text] [Related]
20. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]